$11.33
0.50[4.62%]
Last update: 4:00PM Get Real Time Here
Third Harmonic Bio
(NASDAQ:THRD)Latest News for Third Harmonic Bio Stock (NASDAQ:THRD)
Third Harmonic Bio Stock (NASDAQ: THRD)
Categories: All
Tuesday, March 26, 2024
Thursday, January 04, 2024
Thursday, November 09, 2023
Monday, October 02, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Tuesday, July 25, 2023
Thursday, May 11, 2023
Wednesday, March 29, 2023
Friday, February 03, 2023
Friday, January 27, 2023
Friday, January 13, 2023
Tuesday, January 10, 2023
Wednesday, December 21, 2022
Friday, December 16, 2022
- Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022Benzinga Insights - Dec 16, 2022, 10:01AM
- Morgan Stanley Downgrades Third Harmonic Bio to Equal-Weight, Lowers Price Target to $5Benzinga Newsdesk - Dec 16, 2022, 8:08AM
- Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6Benzinga Newsdesk - Dec 16, 2022, 6:02AM
Thursday, December 15, 2022
- Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Dec 15, 2022, 1:28PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Dec 15, 2022, 12:32PM
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Dec 15, 2022, 11:19AM
- Third Harmonic Bio Stock Plummets After Trial Discontinuation On Safety ConcernsVandana Singh - Dec 15, 2022, 10:10AM
- Third Harmonic Bio shares are trading lower after the company announced discontinuation of its Phase 1b study of THB001 in chronic inducible urticaria.Benzinga Newsdesk - Dec 15, 2022, 8:46AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 15, 2022, 8:07AM
- Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market SessionLisa Levin - Dec 15, 2022, 7:47AM
- Third Harmonic Bio Announces Discontinuation Of Phase 1b Study Of THB001 In Chronic Inducible UrticariaBenzinga Newsdesk - Dec 15, 2022, 7:07AM
Wednesday, November 09, 2022
Monday, October 10, 2022
- Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022Benzinga Insights - Oct 10, 2022, 10:08AM
- Jefferies Initiates Coverage On Third Harmonic Bio with Buy Rating, Announces Price Target of $30Benzinga Newsdesk - Oct 10, 2022, 8:40AM
- Morgan Stanley Initiates Coverage On Third Harmonic Bio with Overweight Rating, Announces Price Target of $34Benzinga Newsdesk - Oct 10, 2022, 7:39AM
- Cowen & Co. Initiates Coverage On Third Harmonic Bio with Outperform RatingBenzinga Newsdesk - Oct 10, 2022, 6:13AM
Thursday, October 06, 2022
Tuesday, October 04, 2022
Wednesday, September 28, 2022
Thursday, September 22, 2022
Tuesday, September 20, 2022
Monday, September 19, 2022
Friday, September 16, 2022
Thursday, September 15, 2022
- Third Harmonics Shares Opened For Quote At $20.50; IPO Priced $17/ShareBenzinga Newsdesk - Sep 15, 2022, 11:37AM
- Third Harmonic Bio Shares Indicating $22.57, IPO Priced At $17/ShareBill Haddad - Sep 15, 2022, 10:51AM
- Third Harmonics Shares Opened For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced $17/ShareBenzinga Newsdesk - Sep 15, 2022, 10:11AM
- IPOs for Thursday September 15, 2022: Corebridge Financial, 80M Shares Priced at $21/Share; Third Harmonic Bio, 17M Shares Priced at $17/ShareCharles Gross - Sep 15, 2022, 6:07AM